Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 22.37B | 38.72B | 19.55B | 16.49B | 14.17B | 14.58B |
Gross Profit | 37.01B | 22.30B | 20.18B | 16.49B | 14.17B | 14.58B |
EBITDA | 6.88B | 13.71B | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | 11.21B | 11.29B | 10.06B | 8.19B | 6.80B | 4.72B |
Balance Sheet | ||||||
Total Assets | 840.82B | 827.22B | 739.30B | 743.37B | 686.07B | 649.94B |
Cash, Cash Equivalents and Short-Term Investments | 0.00 | 139.06B | 117.67B | 114.30B | 108.34B | 101.48B |
Total Debt | 0.00 | 64.90B | 44.83B | 47.08B | 53.86B | 45.21B |
Total Liabilities | 772.08B | 758.39B | 677.05B | 686.30B | 628.36B | 595.29B |
Stockholders Equity | 68.70B | 68.79B | 62.06B | 56.89B | 57.53B | 54.63B |
Cash Flow | ||||||
Free Cash Flow | 7.96B | 14.43B | 4.45B | 2.10B | 7.16B | 24.33B |
Operating Cash Flow | 8.21B | 15.34B | 5.17B | 2.77B | 7.73B | 24.88B |
Investing Cash Flow | -31.67B | -1.24B | 727.00M | -694.00M | -1.60B | -415.00M |
Financing Cash Flow | 34.07B | -6.60B | -9.19B | -3.89B | -2.58B | -2.37B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $75.61B | 13.12 | 11.19% | 3.37% | 3.60% | 22.68% | |
78 Outperform | $176.49B | 23.17 | 13.78% | 0.17% | 2.48% | 0.36% | |
77 Outperform | $109.35B | 12.89 | 17.10% | 3.95% | 4.50% | 8.21% | |
73 Outperform | $117.55B | 18.83 | 17.47% | 0.78% | 17.32% | 12.99% | |
73 Outperform | $70.19B | 9.88 | 20.49% | 7.76% | 5.44% | 2.81% | |
65 Neutral | $82.51B | 14.01 | 8.69% | 2.43% | -2.22% | 24.37% | |
58 Neutral | HK$111.27B | 6.73 | -5.15% | 3.95% | 9.05% | -47.66% |